Genethon is currently sponsoring two gene therapy projects that have reached clinical trial phase, and is involved in a further eleven projects in preclinical or research stages. These projects, which are being developed either internally at Genethon or as part of partnerships, involve neuromuscular diseases, pathologies of the immune system, of the eye, and other rare diseases.
Products
Research
Pre-clinical phase
Phase I or I/II